United States Court of Appeals for the Federal Circuit ______________________ August 16, 2011 ERRATUM ______________________ Appeal No. 2010-1102,-1103 IN RE BRIMONIDINE PATENT LITIGATION ---------------------------------------------- ALLERGAN, INC., v. EXELA PHARMSCI INC. and EXELA PHARMSCI PVT., LTD., and APOTEX INC. and APOTEX CORP.,

Decided: May 19, 2011 Precedential Opinion ______________________ Please make the following change: Page 11, footnote 1, lines 9-10, the text should be changed to read Dose Response Study” (“Derick”). The dissent characterizes that article